Preferred Label : Erythrocytosis, familial, 2;
Symbol : ECYT2;
CISMeF acronym : ECYT2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Polycythemia, vhl-dependent;
Included titles and symbols : Polycythemia, chuvash type;
Description : Familial erythrocytosis-2 is an autosomal recessive disorder characterized by increased
red blood cell mass, increased serum levels of erythropoietin (EPO; 133170), and normal
oxygen affinity. Patients with ECYT2 carry a high risk for peripheral thrombosis and
cerebrovascular events (Cario, 2005). Familial erythrocytosis-2 has features of both
primary and secondary erythrocytosis. In addition to increased circulating levels
of EPO, consistent with a secondary, extrinsic process, erythroid progenitors are
also hypersensitive to EPO, consistent with a primary, intrinsic process (Prchal,
2005).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the VHL gene (VHL, 608537.0014);
Laboratory abnormalities : Increased serum erythropoietin (EPO, 133170); Increased serum vascular endothelial growth factor (VEGF, 192240); Increased serum plasminogen activator inhibitor-1 (PAI1, 173360); Normal leukocyte and platelet counts;
Prefixed ID : #263400;
Origin ID : 263400;
UMLS CUI : C1837915;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)